Entire cohort | Bladder | |||||
---|---|---|---|---|---|---|
Unadjusted | Adjusted | Unadjusted | Adjusted | |||
n (events) | HR (95% CI) | HR (95% CI) | n (events) | HR (95% CI) | HR (95% CI) | |
Age | ||||||
Continuous | 263 (80) | 1.05 (1.01-1.08) | 1.03 (0.999-1.07) | 258 (80) | 1.05 (1.01-1.08) | 1.03 (0.998-1.07) |
Gender | ||||||
Female | 81 (23) | 1.00 | 1.00 | 78 (23) | 1.00 | 1.00 |
Male | 182 (57) | 1.10 (0.68-1.79) | 0.94 (0.56-1.58) | 180 (57) | 1.06 (0.65-1.73) | 0.91 (0.54-1.54) |
Stage | ||||||
Ta | 114 (15) | 1.00 | 1.00 | 112 (15) | 1.00 | 1,00 |
T1 | 84 (22) | 2.40 (1.24-4.62) | 1.86 (0.86-4.02) | 81 (22) | 2.47 (1.28-7.68) | 2.38 (1.23-4.60) |
T2-4 | 65 (43) | 8.83 (4.88-15.97) | 5.46 (2.41-12.36) | 65 (43) | 8.68 (4.80-15.70) | 7.12 (3.87-13.08) |
Grade | ||||||
Low | 133 (20) | 1.00 | 1.00 | 129 (20) | 1.00 | 1.00 |
High | 130 (60) | 4.02 (2.43-6.68) | 1.44 (0.71-2.92) | 129 (60) | 3.94 (2.37-6.54) | 1.33 (0.65-2.73) |
Smoking | ||||||
Regularly | 93 (30) | 1.00 | 1.00 | 92 (30) | 1.00 | 1.00 |
Occasionally | 15 (4) | 0.76 (0.27-2.17) | 0.90 (0.31-2.58) | 15 (4) | 0.75 (0.26-2.14) | 0.90 (0.31-2.57) |
Former | 113 (32) | 0.86 (0.52-1.42) | 0.73 (0.44-1.21) | 110 (32) | 0.88 (0.53-1.44) | 0.74 (0.45-1.23) |
Never | 42 (14) | 1.04 (0.55-1.95) | 1.22 (0.64-2.33) | 41 (14) | 1.05 (0.56-1.99) | 1.26 (0.66-2.39) |
Ezrin | ||||||
High | 112 (20) | 1.00 | 1.00 | 111 (20) | 1.00 | 1.00 |
Low | 151 (60) | 2.51 (1.52-4.17) | 1.69 (1.00-2.85) | 147 (60) | 2.58 (1.55-4.28) | 1.74 (1.03-2.95) |